RxDoctor Payments Data

Marlene Jarin

Adult Medicine · Miami Beach, FLNPI 1609018134

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $14,403 of the $17,896 with a category attached, or 80.5%. 27 manufacturers reported payments, led by Gilead at 42.3% of the total. Reporting peaked in 2019 at $6,464 and has fallen 62.1% since, to $2,448 in 2025. Among adult medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,896in general payments, 2019–2025

Across 589 payments — averaging $30.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$8K
  • Viiv Healthcare Company$6K
  • Johnson & Johnson$1K
  • Theratechnologies Inc.$639
  • Lilly USA, LLC$533
  • Merck$438
  • plus $2K from 21 others

What the payments were for

  • Consulting fees$2,57014%
  • Travel & lodging$7234%
  • Food & beverage$14,40380%
  • Education$2001%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,896 in reported general payments places this provider in the 95th percentile of 195 adult medicine providers in Florida.

See all adult medicine providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
SerostimSomatropin12$239,274
BiktarvyBictegrav/Emtricit/Tenofov Ala16$59,307
DovatoDolutegravir Sodium/Lamivudine18$51,079
Rosuvastatin Calcium26$683
Lisinopril16$224
Amlodipine Besylate13$129
Zolpidem Tartrate15$80

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
EMD Serono, Inc.Serostim$361$239,27412 claims
GileadBiktarvy$7,565$59,30716 claims
Viiv Healthcare CompanyDovato$5,579$51,07918 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 195 adult medicine providers in Florida.

Other adult medicine in Miami Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →